Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors

Clinical trial NCT07769047 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07769047
Sponsor: Mayo Clinic
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8

Start date: 2026-09-01
Primary completion: 2031-07-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.